ScholarIQanswers from OpenAlex

Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups

PaperCitations, authors & open-access status

Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups have?

ScholarIQcitation count

Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups has 53 citations in the OpenAlex counts ScholarIQ stores.

When was Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups published?

ScholarIQyear

Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups has 2023 year in the ScholarIQ index.

What is the open-access status of Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups?

ScholarIQoa status

Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups has hybrid oa status in the ScholarIQ index.

What is the DOI of Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups?

ScholarIQdoi

The DOI for Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups is on the source record.

What is the PMID of Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups?

ScholarIQpmid

The PMID for Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups is on the source record.

What is the OpenAlex record for Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups?

ScholarIQopenalex

The OpenAlex for Two-year outcomes of leadless vs. transvenous single-chamber ventricular pacemaker in high-risk subgroups is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial